The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids. - Wikidata - wikimedia - TriplyDB

The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids.

The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids.

http://www.wikidata.org/entity/Q37372483

about

VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma.

P2860

Q42371566-A94C5E91-0AB7-4505-A275-6CF3E8112AF3

P2860

The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids.

http://www.wikidata.org/entity/Q37372483

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids.

@en

The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids.

@nl

type

label

The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids.

@en

The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids.

@nl

prefLabel

The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids.

@en

The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids.

@nl

P1433

Q37372483-76075056-E8E3-46C4-A7F7-CEFA03A1B2B9

P1476

Q37372483-D8A9C845-9AC6-435B-80C4-82E07CE0AF7B

P2093

Q37372483-020CAE45-8888-4FC4-8C76-6447994046C7

Q37372483-1A9D8C38-312D-4089-8632-3094B5F32B17

Q37372483-852309F0-F01B-45E1-9D04-01DB0DC79E25

Q37372483-91E3DB20-CFC4-42EA-8F0C-F5C67ABBD75E

Q37372483-A0F3BB2C-F8D0-4E0E-9B00-2C89111871B7

P2860

Q37372483-060F7C5F-ECED-4C53-9E3F-63926D15C0B9

Q37372483-08E3B293-CB0D-4FC9-B58C-9971380D0F4C

Q37372483-0C939BDE-1F52-4259-BDCE-FEA477223282

Q37372483-0D0FCA0B-1B90-4684-AACE-D6741D088AA3

Q37372483-1866A128-997A-4DF1-A316-658B970C12B6

Q37372483-19C3105F-671E-4B80-820F-FC17BA858A83

Q37372483-19ED4D32-4202-4216-805B-D69861E25530

Q37372483-1A0AB90E-5754-440E-B424-5E21F7454173

Q37372483-1EAA8A06-F960-42F4-8B02-A189A8DE0577

Q37372483-234DC3F2-EF7D-4930-8022-8C1F3443E2F6

P2888

Q37372483-77C9E5EF-17CB-4A6E-87AA-37641D3868A0

P304

Q37372483-08A38CF0-AFAF-438B-A6C1-446FE3801640

P31

Q37372483-A8D9C492-CE1C-4A06-80B5-7DBA37E823E2

P356

Q37372483-6F03AB0E-158C-4223-8FBC-8ED308813DBC

P433

Q37372483-C20EE580-D632-4F90-97AE-0502DE22123E

P478

Q37372483-3F2EFEC7-A0BB-49EE-9DFA-F118313A0886

P577

Q37372483-5313186C-264C-4595-8BF1-1255546EE93E

P698

Q37372483-2DF5F155-16B3-48A7-B97D-68364EDE4928

P932

Q37372483-0FE15732-B81A-4E2B-859F-2488E1D619BB

P356

P1433

Cancer Gene Therapy

P1476

The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids.

@en

P2093

H Chen

http://www.w3.org/2001/XMLSchema#string

H Gill

http://www.w3.org/2001/XMLSchema#string

J B Matsumura

http://www.w3.org/2001/XMLSchema#string

S Lubner

http://www.w3.org/2001/XMLSchema#string

Y Somnay

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation

Tissue-specific expression of human achaete-scute homologue-1 in neuroendocrine tumors: transcriptional regulation by dual inhibitory regions

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: An NRG Oncology/Gynecologic Oncology Group study

Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide.

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.

Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors.

P2888

P304

348-354

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CGT.2016.39

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27632933

http://www.w3.org/2001/XMLSchema#string

P932

5083201

http://www.w3.org/2001/XMLSchema#string